The U.S.
Federal Trade Commission (FTC) is reportedly launching a major lawsuit against Hims & Hers Health Inc.
(NYSE:HIMS), claiming the telehealth company unlawfully shared sensitive customer health information with online advertisers and utilized deceptive billing tactics.
Data Shared With Tech Giants Reuters on Wednesday reported that the FTC claims that sensitive medical data was improperly funneled to digital advertising firms, specifically highlighting Meta Platforms Inc.
(NASDAQ:META) and Snap Inc.
